Michael Sarcone
Stock Analyst at Jefferies
(0.14)
# 4,470
Out of 5,124 analysts
9
Total ratings
25%
Success rate
-26.41%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $29 → $36 | $32.73 | +9.99% | 2 | Dec 4, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $160 → $85 | $92.23 | -7.84% | 1 | Oct 24, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $156.15 | -10.34% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $3.29 | -39.21% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $31.46 | +201.97% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $112.91 | +10.71% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $7.87 | +27.06% | 1 | Mar 21, 2023 |
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $32.73
Upside: +9.99%
Inspire Medical Systems
Oct 24, 2025
Downgrades: Hold
Price Target: $160 → $85
Current: $92.23
Upside: -7.84%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $156.15
Upside: -10.34%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $3.29
Upside: -39.21%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $31.46
Upside: +201.97%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $112.91
Upside: +10.71%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $7.87
Upside: +27.06%